Search Videos and More
News
U.S. News & World Report Names Dana-Farber Brigham Cancer Center Among Nations’ Best for 2023-2024
For the 23rd consecutive year, Dana-Farber Brigham Cancer Center has been recognized as a Best Hospital for cancer care by U.S. News & World Report.
News
Live Cell Imaging IDs Bad Actors in Cancer and Finds Possible Ways to Defeat Them
Most forms of chemotherapy are designed to kill cancer cells. But some cancer cells survive. Those that do can cause the cancer to relapse.
News
Origins of Glioma Brain Cancer Found to be in the Epigenome
While cancers often originate from mutations and other alterations of cells' DNA, researchers in the Bernstein Laboratory at Dana-Farber and the Broad Institute of MIT and Harvard have found that gliomas – incurable brain tumors – can arise due to changes in the epigenome, the collection of compounds that are deposited on DNA and alter gene activity without changing the sequence of DNA itself.
News
Prostate Cancer Disparities Drive Quest for Equity
Black men, particularly men of West African descent, are nearly twice as likely to be diagnosed with prostate cancer than Caucasian men, and three times more likely than Asian men.
News
New Targeted Treatments Emerge for Gastric and Esophageal Cancer
For years, patients with advanced forms of gastric and esophageal cancer have had relatively few treatment options.
News
Obesity and High Weight Linked to Adverse Outcomes In Leukemia Treatment
As the United States faces a growing obesity epidemic, scientists are taking a closer look at how body weight can affect health outcomes.
News
ChatGPT and Medicine: The Good, the Bad, and the Bizarre
The artificial intelligence chatbot ChatGPT has wowed users with its seemingly human-like ability to generate and respond to language, and worried others by that very same ability.
News
Making Natural Killer Cells Smarter to Improve Cell Therapy
Could natural killer cells build the foundation for a new vision of immunotherapy?
Document
Treatment Guidelines: Elacestrant for Advanced Estrogen Receptor-Positive Breast Cancer
The Breast Oncology Center at Dana-Farber Brigham Cancer Center held multidisciplinary meetings on February 24 and May 5, 2023 to discuss recommendations for the use of elacestrant in patients with advanced estrogen receptor-positive breast cancer.
Course
Breast Cancer: New Horizons, Current Controversies
July 20-22, 2023 Live Virtual and In Person Westin Copley Place, Boston, MA
News
Dana-Farber Research Publication, 7.1.2023
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from June 1 through June 15.
News
Bispecific Antibodies for Multiple Myeloma: Six Things Your Patients Should Know
In 2022, the drug teclistamab became the first bispecific antibody to be approved by the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.